TGA approves Moderna as adolescent booster An ongoing study demonstrates that the booster produces a similar immune response in this cohort to adults aged 18–25, the regulator says.
How can we encourage COVID booster uptake? Millions of Australians still have not had a third dose. Associate Professor Holly Seale and Jessica Kaufman investigate what might convince them.
$11 million COVID booster campaign yet to have an impact Halfway through the advertising blitz, Australia’s third dose coverage has increased by just 0.3%. GPs say the money would be better spent supporting providers.
Extra 7.4 million eligible for fourth COVID shot ATAGI recommends that everyone aged 50–64 should get a second booster, while those between 30–49 may also receive a fourth dose.
‘Shocking’: Migrants more than twice as likely to die of COVID-19 The burden of the pandemic hugely and disproportionately lies among those born overseas, official ABS figures show.
Australian-first study reveals boosters’ efficacy against Omicron People who received three doses of COVID-19 vaccine had 65% greater protection against hospitalisation or death than those who only had two.
ATAGI updates post-infection vaccination advice The new recommendation reflects evidence that a longer gap between COVID-19 infection and vaccination will improve immune responses.
What impact are boosters having on illness and death in Australia? The distinct patterns of vaccination and infection across different states could already be giving a clear clue on booster efficacy.
Extra booster dose recommended by ATAGI The rollout of additional COVID-19 vaccine doses for those ‘at greatest risk of severe illness’ will commence ahead of winter to tie in with flu vaccination.
T cells provide long-lasting immunity against COVID: Study According to new Australian research, the T cell response to COVID-19 lasts for at least 15 months.